Experience

• • Blackstone Group in its acquisition of HealthEdge, a leading technology business that delivers next generation Core Administrative Processing Systems (CAPS) solutions to healthcare businesses.
  • Allergan in its sale of Brazikumab to AstraZeneca and Zenpep to Nestle.
  • Clayton, Dubilier & Rice and BrandSafway in the over $6 billion sale of BrandSafway to Brookfield Business Partners L.P. and CD&R Fund X.
  • TPG Growth in its takeover of the existing assets of the Abraaj Group’s $1 billion Global Healthcare Fund.
  • Tata Group in its settlement in relation to telecom tower arrangements in India.
  • The Poddar family in the sale of their remaining shareholding in Ashirvad Pipes to Aliaxis.
  • Glendower Capital in its role as part of a consortium of blue-chip institutional investors to invest approximately $530 million in six companies controlled by Argonne Capital Group.
  • Precision Medicine Group in a new $275 million investment.
  • Clayton, Dubilier & Rice and Ardian in the €177 million sale of shares in SPIE, representing their last remaining investment in the company.
  • Deutsche Bank in its role as the depositary bank in a Russian issuer’s $270 million block trade of shares and global depositary receipts.
  • Clayton, Dubilier & Rice and SSA Investments in the £454.3 million sale of shares in B&M.
  • HarbourVest Partners in its acquisition of stakes in MML Capital Partners Funds V and VI from Varma Mutual Fund Pension Insurance Company.
  • Clayton, Dubilier & Rice and its co-investors in the €380 million sale of shares in SPIE.
  • The Bank of New York Mellon in its role as the depositary bank in Nova Ljubljanska Banka’s €567 million offering and listing of global depositary receipts.
  • Caisse de dépôt et placement du Québec in its investment in Datamars.
  • Reynolds Group Holdings in the issuance of $2.1 billion senior secured fixed and floating rate notes and $800 million senior notes.